Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,280
Closed -$26K 190
2017
Q3
$26K Hold
1,280
﹤0.01% 137
2017
Q2
$22K Sell
1,280
-320
-20% -$5.88K ﹤0.01% 130
2017
Q1
$28K Sell
1,600
-983
-38% -$15.9K ﹤0.01% 124
2016
Q4
$39K Buy
+2,583
New +$39.1K 0.01% 75
2015
Q4
Sell
-27,523
Closed -$319K 168
2015
Q3
$319K Hold
27,523
0.05% 41
2015
Q2
$375K Buy
+27,523
New +$409K 0.13% 39
2015
Q1
Sell
-15,383
Closed -$281K 177
2014
Q4
$281K Buy
15,383
+22
+0.1% +$369 0.07% 164
2014
Q3
$249K Sell
15,361
-22
-0.1% -$357 0.04% 169
2014
Q2
$236K Hold
15,383
0.03% 219
2014
Q1
$227K Buy
15,383
+4
+0% +$54 0.04% 225
2013
Q4
$196K Buy
15,379
+377
+3% +$4.33K 0.03% 230
2013
Q3
$144K Buy
15,002
+13,445
+864% +$148K 0.02% 250
2013
Q2
$18K Buy
+1,557
New +$15.9K 0.21% 45

Other funds holding HPQ

Hirtle Callaghan & Co's HPQ Position: Q4 2017 in Review

Hirtle Callaghan & Co sold out of HP (HPQ) in Q4 2017, closing a stake of 1,280 shares — an estimated $26K sold.

Hirtle Callaghan & Co first reported a position in HPQ in Q2 2013 and held it in 13 quarters. The position peaked at $375K in Q2 2015. 914 funds tracked by Wall St. Rank hold HPQ as of Q4 2017.

  • Hirtle Callaghan & Co reported no remaining HP position as of Q4 2017 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 1,280 HP shares in Q4 2017, an estimated $26K.
  • Hirtle Callaghan & Co first reported a position in HP in Q2 2013 and held it in 13 quarters.
  • Hirtle Callaghan & Co's HP position peaked at $375K in Q2 2015.
  • 914 funds tracked by Wall St. Rank held HP as of Q4 2017.

Based on Hirtle Callaghan & Co's 13F filing for Q4 2017, filed 17 Jan 2018.